(Q34449575)

English

Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

author name string

Toze CL

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Galal A

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Barnett MJ

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Shepherd JD

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Conneally EA

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Hogge DE

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Nantel SH

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Nevill TJ

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sutherland HJ

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Connors JM

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Voss NJ

11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Kiss TL

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Messner HA

13

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Lavoie JC

14

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Forrest DL

15

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Song KW

16

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Smith CA

17

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Lipton J

18

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

825-830

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705130

0 references

B-cell chronic lymphocytic leukemia: a bird of a different feather

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Richter's syndrome after allogeneic stem cell transplantation for chronic lymphocytic leukaemia successfully treated by withdrawal of immunosuppression, and donor lymphocyte infusion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of UnmutatedVHGene in Patients With Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: A report of 12 patients from a single institution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

21 January 2018

Chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

7 January 2021

based on heuristic

inferred from DOI database lookup

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete remission of tumour with interleukin 2 therapy in a patient with non-Hodgkin's lymphoma post allogeneic bone marrow transplant associated with polyclonal T-cell bone marrow lymphocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

7 January 2021

based on heuristic

inferred from DOI database lookup

Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of graft-versus-leukemia effect in a patient with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705130

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705130

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34449575&oldid=1954799634"